Was bedeutet "Clear"?
Das Tier trägt die Mutation nicht. Es wird nicht zur Krankheit kommen und werde es nicht weitergeben.
Autosomal Dominant Progressive Retinal Atrophy (DPRA) is a genetic eye disorder affecting dogs. DPRA leads to progressive vision loss and eventual blindness if left undetected and unmanaged. A DNA test for DPRA helps breeders identify carriers, reducing disease prevalence in future litters. Early genetic testing ensures healthier puppies and protects the breed's overall visual health. DPRA DNA testing is simple, accurate, and essential for responsible dog breeding practices. Regular screening empowers dog owners to make informed breeding decisions and protect canine vision. Invest in DPRA genetic testing today for healthier, happier dogs and enhanced breed integrity.
The autosomal dominant progressive retinal atrophy (dPRA) DNA test identifies a genetic mutation causing vision loss in dogs. dPRA is inherited as an autosomal dominant trait, meaning only one affected copy of the gene is sufficient for disease to manifest. Early genetic testing allows breeders and owners to detect carriers and affected individuals, guiding responsible breeding practices. Regular screening can help reduce the prevalence of dPRA, ensuring healthier generations. Ultimately, DNA testing helps maintain canine eye health and improves overall breed quality.
Dieser DNA-Test ist ab unserem Paket enthalten Basic — und ist auch Teil der Packungen Basic, Standard, Advanced, Complete.
DNA-Testpakete anzeigen →Autosomal Dominant Progressive Retinal Atrophy (dPRA) is a hereditary eye disorder characterized by a gradual degeneration of the retina, leading to progressive vision impairment and eventual blindness in affected dogs. Unlike recessive forms of PRA, this condition is inherited through an autosomal dominant genetic pattern, meaning only one copy of the faulty gene, inherited from either parent, is sufficient to cause the disease.
Dogs affected by dPRA typically exhibit initial symptoms such as night blindness, difficulty navigating in low-light conditions, and increased pupil dilation. Over time, as retinal degeneration progresses, daytime vision also deteriorates, ultimately resulting in complete blindness. The rate of progression and the age at which symptoms first appear can vary significantly among individual dogs.
dPRA follows a dominant inheritance pattern, meaning that a dog with only one affected allele from either parent will exhibit the disease. Consequently, each offspring of an affected dog has a 50% chance of inheriting the disorder. Due to this dominant mode of inheritance, the condition can rapidly spread within a breeding line if not properly monitored and managed.
The DNA test for dPRA identifies the presence or absence of the genetic mutation responsible for the disease. It is a reliable tool allowing breeders and veterinarians to detect affected or carrier animals before clinical signs appear. Early identification is crucial in making informed breeding decisions and helps prevent the propagation of the disorder in future generations.
DNA testing provides vital information to dog owners, breeders, and veterinarians to manage the condition effectively. By identifying affected individuals early, breeding programs can reduce or eliminate the occurrence of dPRA, enhancing breed health and improving the quality of life for dogs. Additionally, early detection allows dog owners to implement appropriate management strategies, such as regular veterinary monitoring, adjustments to home environments, and other supportive care to improve the affected dog's quality of life.
Autosomal Dominant Progressive Retinal Atrophy is a serious genetic condition that significantly impacts canine health and quality of life. DNA testing represents a valuable method for early detection, responsible breeding, and effective disease management. Through careful genetic screening and informed breeding decisions, it is possible to reduce the prevalence and impact of dPRA in canine populations.
Das Tier trägt die Mutation nicht. Es wird nicht zur Krankheit kommen und werde es nicht weitergeben.
Nein. Das Tier ist im Allgemeinen gesund, kann die Mutation aber auf sein Tier übertragen Nachkommen.
Es trägt zwei mutierte Kopien. Klinische Symptome sind abhängig davon zu erwarten die Krankheit. Es sollte nicht gezüchtet werden.
Einige Krankheiten sind geschlechtsgebunden, daher variiert ihre Ausprägung je nach Erkrankung Geschlecht des Tieres.
This DNA test detects the mutation associated with Autosomal Dominant Progressive Retinal Atrophy (dPRA) in order to identify clear, carrier, or at-risk animals.
DNA-Tests helfen Züchtern, sicherere Paarungen zu planen und das Risiko einer Übertragung der Mutation auf die Nachkommen zu verringern.
Der für diesen Test gemeldete Vererbungsmodus ist autosomal-dominant.
This test analyses the mutation RHO c.11C>G.
Nicht unbedingt. Die Interpretation hängt vom Vererbungsmuster und dem resultierenden Genotyp ab.
Kijas James W, Cideciyan Artur V, Aleman Tomas S, Pianta Michael J, PearceKelling Susan E, Miller Brian J, Jacobson Samuel G, Aguirre Gustavo D, Acland Gregory M. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6328-33. doi: 10.1073/pnas.082714499. Epub 2002 Apr 23.
Ihre Privatsphäre, Ihre Wahl
Für den Betrieb der Website verwenden wir unbedingt erforderliche Cookies. Optionale Cookies (z. B. Anbieter eingebetteter Inhalte) sind standardmäßig deaktiviert und werden nur aktiviert, wenn Sie zustimmen. Sie können Ihre Auswahl jederzeit über die Schaltfläche „Cookies“ ändern.
Erforderlich für Kernfunktionen und Sicherheit. Immer aktiviert.
Verbessert Funktionen wie das Speichern von Präferenzen oder werbefreie Einbettungen.
Hilft uns, die Nutzung der Website zu verstehen. Standardmäßig deaktiviert.
Werbung/Tracking über Websites hinweg (einige Video-/Karten-Einbettungen). Standardmäßig deaktiviert.